Table 2 Selected clinical parameters, the size of CAP lesion and the concentration of inflammatory markers in the control group, in patients with ≤ 50 years of age and with > 50 years of age, in subgroup of patients with oldest age and the largest the size of CAP lesion, and the group of all patients, the median (min- max)

Age

40(32–50)

41(32–50)

63(58–69)*,***

65(58–69)*,***

61(32–69)*,***

BMI (kg/m² )

23(21–25)

23(20–28)

25(21–38)

26(22–38)*

24(20–38)

sCAP

-

24(4–56)

32(9–120),***

34(23–120),***

32(4–120),***

IL6 (pg/ml)

0.35(0.22–0.55)

0.56(0.13–2.09)

1.17(0.24–4.20)*

1.23(0.40–4.20)*

1.06(0.13–4.20)*

TNF-α (pg/ml)

1.09(0.42–1.55)

1.95(0.31–6.68)

3.96(0.83–8.77)*

4.97(0.92–8.77)*,***

3.37(0.31–8.77)*

LpPLA2(ng/ml)

57(32–93)

153(32–328)*

200(98–328)*

213(172–275)*

188(32–328)*

hsCRP mg/L

0.014(0.017–0.075)

0.268(0.017–0.620)**

0.367(0.010–1.10)**,***

0.424(0.010–1.10**,***

0.338(0.010–1.10)**,***